Truth/Lies
All posts tagged Truth/Lies
‘Some 13 years after the end of a civil war that saw 100,000 deaths, Sri Lanka is once again on the cusp of serious violence. Earlier today, the police opened fire on protesters in the town of Rambukkana. One person has died and at least ten people are said to be in critical condition. It’s the first use of deadly force against demonstrators who seem to have filled the entire island in recent weeks. Grainy footage shows half-conscious bodies being carried into hospital, bullet casings littering the quiet palm-lined streets.
This was meant to be a time of celebration. Buddhists are marking the new year while the country’s Muslim minority observe Ramadan. Instead, the country has been brought to a standstill by nationwide protests demanding that President Gotabaya Rajapaksa resign amid a crippling economic crisis.
Sri Lanka’s capital, Colombo, is now a ghost town. The savings of the country’s burgeoning middle classes have become worthless: the Sri Lankan Rupee is now the world’s worst-performing currency. India’s southern neighbour owes international lenders more than £21 billion, with just £1.7 billion in reserves. Shops and restaurants are closed and armed police patrol the streets. The price of vegetables has increased fivefold since 2021, while the cost of rice has doubled. Many residents say they are unable to eat more than one meal a day.
Rajapaksa, a Sinhalese Buddhist, was elected President in 2019 following the Easter Sunday terror attacks. To many Sri Lankans – particularly the country’s Sinhalese Buddhist majority, around 70 per cent of the population – he seemed the obvious choice to restore law and order, having served as defence secretary during the civil war. He is credited with bringing an end to the 26-year conflict, but not without allegedly committing an array of gross human rights abuses against Sri Lanka’s Tamil minority. It’s difficult to find a more polarising figure in South Asian politics.
Since his election, Rajapaksa has faced accusations of economic mismanagement, embezzlement and corruption. His brother, Mahinda, is the country’s Prime Minister and another brother, Basil, was finance minister until he resigned last week along with the rest of the cabinet. Basil implemented a series of ill-advised tax cuts back in 2019; Sri Lanka was subsequently locked out of international debt markets and has had to burn through its foreign exchange reserves to service sovereign bond payments.
The Rajapaksas were also behind a sudden decision to suddenly ban chemical fertilisers last May, without consulting farmers, which led to a disastrous drop in rice yields this year. They claimed that it would protect farmers from harmful chemicals which were causing kidney issues. Unable to afford food imports, Sri Lanka saw yields of domestically-grown rice fall by around 50 per cent.
In order to deal with the surging levels of debt, Sri Lanka announced a blanket ban on non-essential imports last year. Now, everything from milk powder to spare car parts are unavailable. Even school exams have been cancelled because the government can’t afford the paper on which to print the tests.
Fuel, gas and diesel shortages have become common. Sunrise in Colombo is met by crowds of residents heading to petrol stations and waiting, usually in vain, to fill up their vehicles. In an attempt to preserve supplies, the government is enforcing ten-hour daily power cuts across the country.
Unsurprisingly, Sri Lankans are angry. Last Saturday, in the largest protest to date, tens of thousands of Colombo residents took to the streets demanding regime change. Many also called for the Rajapaksa brothers to have their day in court. ‘It was never this bad during the civil war,’ one 43-year-old IT worker in Colombo explains. ‘At least then we had food to eat, power in our homes and fuel in our cars.’
It seems growing numbers of Sri Lankans agree. The weekend before last, Muslim leaders marched side-by-side with saffron-robed Buddhist monks before members of the country’s LGBTQ community joined them to break the Ramadan fast. You find groups of wealthy professionals chanting anti-Rajapaksa slogans alongside poor rickshaw drivers who can no longer afford fuel. Doctors and nurses are becoming a vocal part of the protests.
Meanwhile, Sri Lanka’s largest public medical body, the Government Medical Officers Association, has declared a health emergency. Hospitals have run out of five life-saving drugs and the GMOA says there are shortages of another 180 medicines, as well as a lack of vital surgical and testing equipment. There are reports of several deaths due to a shortage of Tenecteplase, a drug administered to patients after heart attacks. Pharmacies surrounding Colombo’s leading cancer hospital are turning away patients. The GMOA is pleading with Sri Lankan expats to send essential drugs.
Yet the Rajapaksas remain resolute: Gotabaya has refused to resign. The country’s new finance minister, who attempted to quit less than 24 hours in the job, has said that reviving the economy will be a ‘Herculean’ task. He estimates Sri Lanka requires £2.3 billion in aid over the next six months to purchase essentials like food and fuel, in addition to meeting £5.3 billion of debt repayments for the rest of the year.
Many Sri Lankans blame high-interest Chinese loans for the crisis. Already, Sri Lanka has been forced to lease a new mega port to China in lieu of repayments. Spotting an opportunity, India has signed over £760 million of credit to Sri Lanka and talks are underway for a further £1.1 billion of financial support.
Back in Colombo, some are saying this is Sri Lanka’s ‘Arab Spring’ moment, as peaceful protesters seek to overthrow an autocratic government mired in corruption allegations and complicit in gross economic mismanagement. But for now, Sri Lanka’s notorious military continues to support the Rajapaksas. Whether that continues is an open question.
‘We haven’t seen anything like this for decades, there is no gas, no fuel, no food. The whole country is coming out onto the streets,’ one 22-year-old protester says. ‘The Rajapaksas have to go right now or it is going to be the end of us all.’’https://www.spectator.com.au/2022/04/sri-lankas-descent-into-chaos/
I think you will find the following interesting reading for this Easter season https://creationfactfile.com/wp-content/uploads/2022/04/Easter-Eaggs-Bunnies-Bible.pdf
‘Dr. Bryan Ardis, believes White House Chief Medical Advisor Dr. Anthony Fauci knows that the toxic drug remdesivir is killing the people who receive it and is fine with it.
Dr. Ardis wasn’t done. He’s continued to look for the full truth about Covid. And just a few weeks ago, he called me. He said “I need to meet with you, in person.” We’d never met in person before, but he said it was urgent, and he didn’t want to send the information he had electronically. He said the information related to the origins of Covid-19: Where it came from, what it really is, and who is really responsible for it. He said that with the information he had, everything about Covid would come together: how they track it, how the CDC predicts “hotspots,” how people fall ill and die from it.’https://peoplesworldwar.com/dr-bryan-ardis-remdesivir-is-toxic-killing-people/
‘We know that SARS-CoV-2 is a man-made “paravirus” if you will, created in Wuhan/Moderna laboratories and reinforced by mainstream media propaganda. But in the grand scheme, at least the first iteration released onto the world, so-called COVID-19 is a lightweight illness that is mostly just rebranded influenza.
The mRNA and viral vector injections, along with Remdesivir, combine for a quick two-year, $200 billion global racket for big pharma and Bill Gates. Ivermectin is a proven, powerful drug to treat and prevent so-called COVID-19, according to 108 peer-reviewed studies. The Ivermectin Merck patents are long expired. So the cheap, $1-per-dose, Nobel Prize-winning drug poses a serious threat not only to the emergency use authorizations for the lethal injections, but also to the temporary COVID-19 racket. But those simply cannot be the only reasons for the persistent, petulant, childish mainstream media anti-Ivermectin propaganda.
The cancer industry will surpass $522 billion per year by 2028, according to Global Market Insights. Market analytics firm Precedent Research predicts the cancer industrial complex will surpass $581 billion annually by 2030. The COVID Blog™ has chronicled the strong correlation (perhaps causal relationship) between mRNA injections and cancer. Cancer has been a goldmine for big pharma since the 1960s. The average cancer patient is worth about $160,000 to the cancer industrial complex. Big pharma will never offer a cure, nor will the industry allow off-label, cheap, effective cancer treatments.
This blogger has seen scattered studies concluding that Ivermectin not only inhibits cancer cell growth, but also kills cancer cells. Perhaps placing nine said studies into one article can help disrupt the cancer industrial complex and wake up the snoozing masses.
1) American Journal of Cancer Research – 2018
This study by researchers at Unidad de Investigación Biomédica en Cáncer in Mexico concluded:
So far, at least 235 clinically-approved, non-cancer drugs have proven anti-tumor activity either in vitro, in vivo, or even clinically. Among these, ivermectin, an anti-parasitic compound of wide use in veterinary and human medicine, is clearly a strong candidate for repositioning, based on the fact that:
i) it is very safe, causing almost no side-effects other than those caused by the immune and inflammatory responses against the parasite in infected patients, and
ii) it has proven anti-tumor activity in pre-clinical studies. On the other hand, it is now evident that the use of very selective “unitargeted” drugs is commonly associated to early development of resistance by cancer cells, hence the use of “dirty” or “multitargeted” drugs is important to explore.
2) Pharmacological Research – 2020
Some key findings by Chinese researchers at Bengbu Medical College include the following:
- Recent studies have also found that Ivermectin (IVM) could promote the death of tumor cells by regulating the tumor micro-environment in breast cancer.
- In an experiment designed to screen potential drugs for the treatment of leukemia, IVM preferentially killed leukemia cells at low concentrations without affecting normal hematopoietic cells.
- In a study by Hashimoto, it found that IVM inhibited the proliferation of various ovarian cancer cell lines.
- Experiments confirmed that IVM could significantly inhibit the proliferation of five renal cell carcinoma cell lines without affecting the proliferation of normal kidney cells, and its mechanism may be related to the induction of mitochondrial dysfunction.
3) Frontiers in Pharmacology – 2021
Researchers at Henan University in China concluded:
We have demonstrated that ivermectin may regulate the expression of crucial molecules Caspase-3, Bax, Bcl-2, PARP, and Cleaved-PARP in the apoptosis pathway by increasing ROS production and inhibiting the cell cycle in the S phase to inhibit colorectal cancer cells (Figure 11). Therefore, current results indicate that ivermectin might be a new potential anticancer drug for treating human colorectal cancer and other cancers.
4) Molecular Medicine Reports – 2018
Researchers at the National Cancer Institute in Mexico City concluded the following:
Results from the present study demonstrated that ivermectin preferentially targeted the stem cell population in MDA–MB–231 human breast cancer cells. Ivermectin has been demonstrated to be safe, following treatment of millions of patients with onchocerciasis and other parasitic diseases, which makes it a strong candidate for further studies investigating its potential use as a repurposed drug for cancer therapy.
5) Biochemical and Biophysical Research Communications – 2017
Some key findings from researchers at The Second Clinical Medical College in China:
- Ivermectin is preferentially against renal cell carcinoma (RCC) while sparing normal kidney cells.
- RCC tumor growth in vivo is delayed by Ivermectin.
- Ivermectin induces mitochondrial dysfunction and oxidative stress.
- RCC has increased mitochondrial biogenesis than normal kidney cells.
6) EPMA Journal – 2020
Researchers at three Chinese institutions concluded:
Those findings provided the potential targeted lncRNA-EIF4A3-mRNA pathways of ivermectin in ovarian cancer, and constructed the effective prognostic model, which benefits discovery of novel mechanism of ivermectin to suppress ovarian cancer cells, and the ivermectin-related molecule-panel changes benefit for its personalized drug therapy and prognostic assessment towards its predictive, preventive, and personalized medicine (PPPM) in ovarian cancers.
7) BMC Cancer – 2021
Chinese researchers at Henan University, concluded the following:
We demonstrated that ivermectin effectively inhibit the proliferation of esophageal squamous cell carcinoma (ESCC) cells by inducing mitochondrial dysfunction, suppressing NF-κB signaling and promoting apoptosis. Our results suggest that ivermectin may be a potential therapeutic target against ESCC.
8) Cancer Chemotherapy and Pharmacology – 2020
Some key findings from researchers at Instituto Nacional de Cancerologia in Mexico City:
Ivermectin reduced both cell viability and colony formation capacity in the stem cell-enriched population as compared with the parental one. Finally, in tumor-bearing mice ivermectin successfully reduced both tumor size and weight. Our results on the anti-tumor effects of ivermectin support its clinical testing.
9) EMBO Molecular Medicine – 2014
Some key findings by University of Geneva researchers are as follows:
Constitutive activation of canonical WNT-TCF signaling is implicated in multiple diseases, including intestine and lung cancers, but there are no WNT-TCF antagonists in clinical use. We report that Ivermectin inhibits the expression of WNT-TCF targets, mimicking dnTCF, and that its low concentration effects are rescued by direct activation by TCFVP16.
In vivo, Ivermectin selectively inhibits TCF-dependent, but not TCF-independent, xenograft growth without obvious side effects. Given that Ivermectin is a safe anti-parasitic agent used by 200 million people against river blindness, our results suggest its additional use as a therapeutic WNT-TCF pathway response blocker to treat WNT-TCF-dependent diseases including multiple cancers.
whatyareckon 